Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
1.380
-0.030 (-2.13%)
At close: Oct 31, 2024, 4:00 PM
1.390
+0.010 (0.72%)
After-hours: Oct 31, 2024, 6:39 PM EDT
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $173.55 million as of October 31, 2024. Its market cap has increased by 102.27% in one year.
Market Cap
173.55M
Enterprise Value
97.79M
1-Year Change
102.27%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $173.55M, an increase of 179.91%. That is a compound annual growth rate of 8.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 177.30M | 60.74% |
Dec 29, 2023 | 110.30M | 64.87% |
Dec 30, 2022 | 66.90M | -66.98% |
Dec 31, 2021 | 202.60M | 197.94% |
Dec 31, 2020 | 68.00M | 375.52% |
Dec 31, 2019 | 14.30M | 146.55% |
Dec 31, 2018 | 5.80M | -17.14% |
Dec 29, 2017 | 7.00M | 32.08% |
Dec 30, 2016 | 5.30M | -45.36% |
Dec 31, 2015 | 9.70M | -72.36% |
Dec 31, 2014 | 35.10M | -16.03% |
Dec 31, 2013 | 41.80M | -17.06% |
Dec 31, 2012 | 50.40M | -18.71% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Greenwich LifeSciences | 184.03M |
NeuroPace | 183.94M |
Actuate Therapeutics | 180.28M |
Caribou Biosciences | 178.92M |
Inhibikase Therapeutics | 178.73M |
Candel Therapeutics | 175.82M |
Context Therapeutics | 172.50M |
Acumen Pharmaceuticals | 170.62M |